Update on antithrombotic agents in secondary stroke prevention (CROSBI ID 176259)
Prilog u časopisu | pregledni rad (stručni)
Podaci o odgovornosti
Rundek, Tanja ; Bašić Kes, Vanja ; Morović, Sandra ; Demarin, Vida
engleski
Update on antithrombotic agents in secondary stroke prevention
Recurrent stroke is a major cause of morbidity and mortality among stroke survivors. With improved survival after first ischemic stroke, stroke recurrence may account for a greater share of the future annual cost of stroke-related health care. Despite advances in stroke prevention strategies and treatments, stroke recurrence is still the major threat to any stroke survivor. This review discusses antithrombotic therapy in secondary stroke prevention which has a major impact in clinical practice.
stroke; antithrombotic drugs; secondary stroke prevention
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti